Cipla Limited Salbutamol Export Data — India (DGFT 2022–2026)

Name: Cipla Limited Salbutamol Export Records India — #1 Exporter, 2,828 Shipments, $100.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Salbutamol

India Pharmaceutical Trade Intelligence

$148.8M602 Suppliers164 CountriesHS 30049099

ExportsIndia → BRAZIL25.8%India → SOUTH AFRICA24.1%

ImportsIRELAND → India$158.9K UNITED KINGDOM → India$12.5K

#1 Supplier: CIPLA LIMITED

Cipla Limited — Salbutamol Exporter #1 | $100.3M Trade Value | TransData Nexus | TransData Nexus

Cipla Limited — Salbutamol Exporter Profile

Indian Pharmaceutical Exporter · #1 for Salbutamol · $100.3M export value · DGFT Verified

Cipla Limited is the #1 Indian exporter of Salbutamol with $100.3M in export value and 2,828 verified shipments. Cipla Limited holds a 67.4% market share in Salbutamol exports across 41 countries. The company exports 98 pharmaceutical products worth $1.1B across 26 therapeutic categories.

Cipla Limited — Salbutamol Export Profile: Buyers & Destinations

Cipla Limited Salbutamol export treemap — buyers and destination countries | TransData Nexus

Where Does Cipla Limited Export Salbutamol?

Country	Value	Shipments	Share
BRAZIL	$33.1M	1,481	49.9%
SOUTH AFRICA	$7.4M	284	11.2%
COLOMBIA	$4.2M	132	6.4%
NEW ZEALAND	$3.7M	133

Who Are the Top Buyers of Salbutamol from Cipla Limited?

Buyer	Country	Value	Orders
LABORATORIO TEUTO BRASILEIRO S/A	BRAZIL	$23.9M	1,150
LABORATORIO TEUTO BRASILEIRO S A	BRAZIL	$8.3M	294
MEDPRO PHARMACEUTICA (PTY) LTD	SOUTH AFRICA	$4.6M	184
BREATHEFREE LANKA PVT LTD	SRI LANKA	$2.5M	140
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR	TURKEY	$2.4M	69
CIPLA COLOMBIA SAS Y/O DEPOSITO UPS	COLOMBIA	$1.7M	60
REX MEDICAL LTD,	NEW ZEALAND	$1.6M	43
MEDPRO PHARMACEUTICA PTY LTD	SOUTH AFRICA	$1.2M	32
REX MEDICAL LTD	NEW ZEALAND	$1.2M	53
CIPLA COLOMBIA SAS Y O DEPOSITO UP	COLOMBIA	$1.1M	33

Cipla Limited supplies Salbutamol to 119 buyers globally. The largest buyer is LABORATORIO TEUTO BRASILEIRO S/A (BRAZIL), followed by LABORATORIO TEUTO BRASILEIRO S A (BRAZIL) and MEDPRO PHARMACEUTICA (PTY) LTD (SOUTH AFRICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Salbutamol Formulations Does Cipla Limited Export?

Product Description / Formulation	Value	Shipments
AERODINI HFA INHALER (SALBUTAMOL SULPHAT	$7.2M	275
AERODINI HFA INHALER (SALBUTAMOL PRESSURISED INHALATION 100MCG) (1 X200 MD) .	$6.0M	162
AERODINI HFA INHALER (SALBUTAMOL SULPHATE 100MCG)	$4.2M	270
AERODINI HFA INHALER (SALBUTAMOL SULPHATE 100 MCG)	$3.8M	198
AERODINI HFA INHALER SALBUTAMOL SULPHATE 100 MCG	$3.5M	133
AERODINI HFA INHALER SALBUTAMOL SULPHAT	$2.5M	92
AERODINI HFA INHALER (SALBUTAMOL SULPHATE 100 MCG)NOS	$1.8M	204
ASTHAVENT 200MD CFC FREE INHALER (SALBUTAMOL SULPHATE 100MCG)	$1.6M	61
ASTHAVENT ECOHALER (SALBUTAMOL SULPHATE INHALER 100MCG)	$1.3M	48
AERODINI HFA INHALER SALBUTAMOL PRESSURISED INHALATION 100MCG 1 X 200 MD	$1.1M	30

Cipla Limited exports 517 distinct Salbutamol formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AERODINI HFA INHALER (SALBUTAMOL SULPHAT with 275 shipments worth $7.2M.

How Does Cipla Limited Compare to Nearest Salbutamol Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	CIPLA LIMITED ★	$100.3M	2,828	41	$35.5K
2	GLENMARK PHARMACEUTICALS LIMITED	$5.7M	298	11	$19.3K
3	AHLCON PARENTERALS (INDIA) LIMITED	$4.9M	117	4	$42.1K

Cipla Limited ranks #1 among 602 Indian Salbutamol exporters. Average shipment value of $35.5K compared to the market average of $217.4K. The closest competitors by value are GLENMARK PHARMACEUTICALS LIMITED and AHLCON PARENTERALS (INDIA) LIMITED.

Which Indian Ports Ship Salbutamol Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	2,198	15.3%
SAHAR AIR	2,141	14.9%
DELHI AIR CARGO ACC (INDEL4)	1,530	10.7%
NHAVA SHEVA SEA (INNSA1)	1,497	10.4%
DELHI AIR	1,064	7.4%
JNPT/ NHAVA SHEVA SEA	1,036	7.2%
JNPT	842	5.9%
Bombay Air	568	4.0%

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Salbutamol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Cipla Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 2,828 individual customs records matching Cipla Limited exporting Salbutamol, covering 517 formulations to 47 countries via 119 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 164+ countries, 1,775+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Salbutamol

Salbutamol

Cipla Limited — Salbutamol Exporter Profile

Cipla Limited — Salbutamol Export Profile: Buyers & Destinations

Where Does Cipla Limited Export Salbutamol?

Who Are the Top Buyers of Salbutamol from Cipla Limited?

What Is India's Total Salbutamol Export Value and How Much Does Cipla Limited Contribute?

What Is the Average Shipment Value for Cipla Limited's Salbutamol Exports?

How Does Cipla Limited Compare to Other Indian Salbutamol Exporters?

What Salbutamol Formulations Does Cipla Limited Export?

Regulatory Requirements: Exporting Salbutamol to Key Markets

Brazil — ANVISA

South Africa — SAHPRA

How Does Cipla Limited Compare to Nearest Salbutamol Exporters?

Which Indian Ports Ship Salbutamol Exports?

What Other Respiratory Products Does Cipla Limited Export?

Salbutamol — Export Intelligence Video

Geopolitical & Trade Policy Impact on Cipla Limited's Salbutamol Exports

Cipla Limited — Regulatory Compliance & Quality Standards

About Cipla Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Salbutamol Export Data from Cipla Limited

Salbutamol Stats

Company Overview

Top Products by Cipla Limited

Related Analysis

Need Detailed Export Data?

Data Source